Philip Hogg
#110,099
Most Influential Person Now
Australian biochemical researcher
Philip Hogg's AcademicInfluence.com Rankings
Philip Hoggbiology Degrees
Biology
#11314
World Rank
#14701
Historical Rank
Molecular Biology
#2410
World Rank
#2447
Historical Rank
Biochemistry
#2476
World Rank
#2632
Historical Rank
Download Badge
Biology
Philip Hogg's Degrees
- PhD Biochemistry University of Melbourne
Why Is Philip Hogg Influential?
(Suggest an Edit or Addition)According to Wikipedia, Philip Hogg is an Australian biochemical researcher and an academic. He is Head of ACRF Centenary Cancer Research Center at the Centenary Institute and Honorary Professor at the NHMRC Clinical Trials Centre at the University of Sydney.
Philip Hogg's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Disulfide bonds as switches for protein function. (2003) (520)
- Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy. (1989) (368)
- Disulfide isomerization switches tissue factor from coagulation to cell signaling (2006) (346)
- Arsenical-based cancer drugs. (2007) (340)
- Allosteric Disulfide Bonds (2006) (268)
- Protein profiles associated with survival in lung adenocarcinoma (2003) (265)
- Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase (2000) (258)
- Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1 (2002) (198)
- Evidence for activation of tissue factor by an allosteric disulfide bond. (2006) (192)
- Redox Control of Exofacial Protein Thiols/Disulfides by Protein Disulfide Isomerase* (1999) (174)
- Generation of Angiostatin by Reduction and Proteolysis of Plasmin (1997) (154)
- Mitochondria as cancer drug targets. (2004) (145)
- A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells. (2003) (142)
- Control of Von Willebrand Factor Multimer Size by Thrombospondin-1 (2001) (134)
- Anticardiolipin Antibodies Block the Inhibition by β2-Glycoprotein I of the Factor Xa Generating Activity of Platelets (1993) (133)
- Allosteric disulfide bonds. (2006) (123)
- Physical Proximity and Functional Association of Glycoprotein 1bα and Protein-disulfide Isomerase on the Platelet Plasma Membrane* (2000) (122)
- Protein-Protein Interaction between Fli-1 and GATA-1 Mediates Synergistic Expression of Megakaryocyte-Specific Genes through Cooperative DNA Binding (2003) (121)
- Presence of closely spaced protein thiols on the surface of mammalian cells (2000) (114)
- Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury. (2010) (110)
- Reactive Oxygen Species and p38 Mitogen-activated Protein Kinase Mediate Tumor Necrosis Factor α-Converting Enzyme (TACE/ADAM-17) Activation in Primary Human Monocytes* (2011) (97)
- Post-translational control of protein function by disulfide bond cleavage. (2013) (96)
- Allosteric disulfide bonds in thrombosis and thrombolysis (2006) (95)
- Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13. (2004) (92)
- Beta2‐glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant (1996) (90)
- Angiostatin Formation Involves Disulfide Bond Reduction and Proteolysis in Kringle 5 of Plasmin* (1999) (88)
- Disulfide bond acquisition through eukaryotic protein evolution. (2011) (85)
- Encryption and decryption of tissue factor (2013) (85)
- A substrate-driven allosteric switch that enhances PDI catalytic activity (2016) (84)
- Control of blood proteins by functional disulfide bonds. (2014) (78)
- Exposure of the cryptic Arg-Gly-Asp sequence in thrombospondin-1 by protein disulfide isomerase. (1998) (77)
- Search for allosteric disulfide bonds in NMR structures (2007) (74)
- Thrombospondin 1 as an Enzyme Inhibitor (1994) (69)
- Necrotic platelets provide a procoagulant surface during thrombosis. (2015) (68)
- Evaluation of equilibrium constants for antigen-antibody interactions by solid-phase immunoassay: the binding of paraquat to its elicited mouse monoclonal antibody. (1987) (64)
- Interaction of vitamin K-dependent protein Z with thrombin. Consequences for the amidolytic activity of thrombin and the interaction of thrombin with phospholipid vesicles. (1991) (64)
- Cross-strand disulphides in cell entry proteins: poised to act. (2004) (64)
- Autoregulation of von Willebrand factor function by a disulfide bond switch (2018) (63)
- Beta 2 glycoprotein I is a substrate of thiol oxidoreductases. (2010) (62)
- Role of Thrombospondin-1 in Control of von Willebrand Factor Multimer Size in Mice* (2004) (61)
- Organic arsenicals as efficient and highly specific linkers for protein/peptide-polymer conjugation. (2015) (61)
- Interaction of platelet-derived growth factor with thrombospondin 1. (1997) (59)
- Thrombospondin 1 is a tight-binding competitive inhibitor of neutrophil cathepsin G. Determination of the kinetic mechanism of inhibition and localization of cathepsin G binding to the thrombospondin 1 type 3 repeats. (1993) (59)
- Noninvasive imaging of cell death using an Hsp90 ligand. (2011) (56)
- Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. (2008) (56)
- Binding of Fibrin Monomer and Heparin to Thrombin in a Ternary Complex Alters the Environment of the Thrombin Catalytic Site, Reduces Affinity for Hirudin, and Inhibits Cleavage of Fibrinogen* (1996) (55)
- Secretion of phosphoglycerate kinase from tumour cells is controlled by oxygen-sensing hydroxylases. (2004) (55)
- Allosteric disulfides: Sophisticated molecular structures enabling flexible protein regulation (2019) (55)
- Thrombospondin is a slow tight-binding inhibitor of plasmin. (1992) (54)
- Redox control of β2-glycoprotein I–von Willebrand factor interaction by thioredoxin-1 (2010) (54)
- Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase. (1993) (53)
- Heparin promotes the binding of thrombin to fibrin polymer. Quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex. (1990) (52)
- Mitochondrial Metabolism Inhibitors for Cancer Therapy (2011) (50)
- The tumour metabolism inhibitors GSAO and PENAO react with cysteines 57 and 257 of mitochondrial adenine nucleotide translocase (2012) (49)
- Redox control on the cell surface: implications for HIV-1 entry. (2003) (48)
- Lateral self-association of VWF involves the Cys2431-Cys2453 disulfide/dithiol in the C2 domain. (2011) (48)
- Global redox proteome and phosphoproteome analysis reveals redox switch in Akt (2019) (48)
- Catalysis of disulfide isomerization in thrombospondin 1 by protein disulfide isomerase. (1996) (47)
- Contribution of allosteric disulfide bonds to regulation of hemostasis (2009) (47)
- Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis. (2012) (46)
- Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates. (1990) (45)
- Zinc is a potent and specific inhibitor of IFN-λ3 signalling (2017) (45)
- Dual-targeting of aberrant glucose metabolism in glioblastoma (2015) (45)
- Effects of Ca2+ binding on the protease module of factor Xa and its interaction with factor Va. Evidence for two Gla-independent Ca(2+)-binding sites in factor Xa. (1993) (45)
- Evidence for a Domain-Swapped CD4 Dimer as the Coreceptor for Binding to Class II MHC1 (2006) (45)
- Control of mature protein function by allosteric disulfide bonds. (2011) (44)
- Platelet Protein Disulfide Isomerase Promotes Glycoprotein Ib&agr;–Mediated Platelet-Neutrophil Interactions Under Thromboinflammatory Conditions (2019) (43)
- Plasmin Reduction by Phosphoglycerate Kinase Is a Thiol-independent Process* (2002) (42)
- Effects of ligand multivalency in binding studies: a general counterpart of the Scatchard analysis. (1985) (40)
- Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosol. (2009) (40)
- Targeting allosteric disulphide bonds in cancer (2013) (40)
- Quantitative affinity chromatography: further developments in the analysis of experimental results from column chromatography and partition equilibrium studies. (1984) (40)
- Mechanism of selectivity of an angiogenesis inhibitor from screening a genome-wide set of Saccharomyces cerevisiae deletion strains. (2005) (39)
- Metabolism of the Tumor Angiogenesis Inhibitor 4-(N-(S-Glutathionylacetyl)amino)phenylarsonous Acid* (2008) (39)
- Modulation of Thrombin and Heparin Activities by Fibrin (1997) (39)
- Abstract 3228: Dichloroacetate reverses the Warburg effect, inhibiting growth and sensitizing breast cancer cells towards apoptosis (2012) (38)
- Disulfide Bond That Constrains the HIV-1 gp120 V3 Domain Is Cleaved by Thioredoxin* (2010) (35)
- Analysis of disulfide bonds in protein structures (2010) (34)
- Redox properties of the tissue factor Cys186-Cys209 disulfide bond. (2011) (34)
- Interaction of human protein Z with thrombin: evaluation of the species difference in the interaction between bovine and human protein Z and thrombin. (1991) (34)
- The von Willebrand factor-reducing activity of thrombospondin-1 is located in the calcium-binding/C-terminal sequence and requires a free thiol at position 974. (2002) (33)
- Mechano-redox control of integrin de-adhesion (2018) (33)
- Lupus anticoagulants form immune complexes with prothrombin and phospholipid that can augment thrombin production in flow. (1999) (33)
- Reduced Monomeric CD4 Is the Preferred Receptor for HIV* (2010) (32)
- Significant correlation between thrombospondin 1 and serine proteinase expression in rheumatoid synovium. (1997) (31)
- A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours (2013) (30)
- Insight into the selectivity of arsenic trioxide for acute promyelocytic leukemia cells by characterizing Saccharomyces cerevisiae deletion strains that are sensitive or resistant to the metalloid. (2008) (30)
- Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids. (1999) (29)
- Targeting allosteric disulphide bonds in cancer (2013) (29)
- Effects of gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IX on factor X activation. Studies using proteolytic fragments of bovine factor IX. (1992) (28)
- Lupus Antibody Bivalency Is Required to Enhance Prothrombin Binding to Phospholipid1 (2001) (28)
- Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response (2018) (27)
- Identification of possible inhibitory reactive centers in thrombospondin 1 that may bind cathepsin G and neutrophil elastase. (1994) (27)
- JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis (2019) (27)
- Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma (2018) (26)
- Effects of solute multivalency in quantitative affinity chromatography: evidence for cooperative binding of horse liver alcohol dehydrogenase to blue Sepharose. (1985) (24)
- Critical importance of the cell system when studying tissue factor de-encryption. (2008) (24)
- Thrombospondin-1 inhibits in vitro megakaryocytopoiesis via CD36. (2003) (24)
- Biological regulation through protein disulfide bond cleavage (2002) (24)
- Modulation of Fibrinolysis by Thrombospondin a (1992) (24)
- Protein-Protein Interaction between Fli-1 and GATA-1 Mediates Synergistic Expression of Megakaryocyte-Specific Genes through Cooperative DNA Binding (2004) (23)
- Allosteric Control of βII-Tryptase by a Redox Active Disulfide Bond* (2013) (23)
- Hypothesis for control of von Willebrand factor multimer size by intra‐molecular thiol‐disulphide exchange (2007) (23)
- Identification and Characterisation of a Platelet GPIb/V/IX‐like Complex on Human Breast Cancers: Implications for the Metastatic Process (2001) (23)
- Identification of structural domains in protein C involved in its interaction with thrombin-thrombomodulin on the surface of endothelial cells. (1992) (22)
- Optical imaging of cell death in traumatic brain injury using a heat shock protein-90 alkylator (2013) (22)
- Extracellular matrix is a source of mitogenically active platelet‐derived growth factor (1996) (21)
- Control of von Willebrand factor multimer size and implications for disease. (2002) (21)
- Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation (2018) (21)
- Protein Disulfide Isomerase in Thrombosis (2015) (20)
- Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2 (2020) (20)
- Optical imaging of treatment-related tumor cell death using a heat shock protein-90 alkylator. (2013) (19)
- The gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IXa beta. Effects on the serine protease module and factor X activation. (1994) (19)
- Para to ortho repositioning of the arsenical moiety of the angiogenesis inhibitor 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide results in a markedly increased cellular accumulation and antiproliferative activity. (2005) (19)
- Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells. (2015) (18)
- Mechanism of dimerization of a recombinant mature vascular endothelial growth factor C. (2014) (18)
- Identification of allosteric disulfides from labile bonds in X-ray structures (2018) (17)
- Use of quantitative affinity chromatography for characterizing high-affinity interactions: binding of heparin to antithrombin III. (1991) (17)
- Pharmaceutical development of the novel arsenical based cancer therapeutic GSAO for Phase I clinical trial. (2012) (17)
- Redox Regulation of Methionine Aminopeptidase 2 Activity* (2014) (17)
- Dependence on Prothrombin for Inhibition of Activated Protein C Activity by Lupus Antibodies (2000) (16)
- Searching for CYP24A1 mutations in cohorts of patients with calcium nephrolithiasis (2013) (16)
- Characterization of a Reduced Form of Plasma Plasminogen as the Precursor for Angiostatin Formation* (2013) (15)
- Inhibition of heparin activity in plasma by soluble fibrin: evidence for ternary thrombin-fibrin-heparin complex formation. (1994) (14)
- Direct Polymerization of the Arsenic Drug PENAO to Obtain Nanoparticles with High Thiol-Reactivity and Anti-Cancer Efficiency. (2018) (14)
- Employing pancreatic tumor γ-glutamyltransferase for therapeutic delivery. (2014) (13)
- Studies of lectin-carbohydrate interactions by quantitative affinity chromatography: systems with galactose and ovalbumin as saccharidic ligand. (1987) (13)
- γ-Crystallin redox–detox in the lens (2018) (13)
- Reprogramming of human fibroblasts into osteoblasts by insulin‐like growth factor‐binding protein 7 (2020) (13)
- Identification of monoclonal antibodies that recognize different disulfide bonded forms of thrombospondin 1. (1996) (13)
- Further probes into quantitative aspects of competitive binding assays: allowance for effects of antigen multivalency in immunoassays. (1987) (13)
- Fibrinogen function achieved through multiple covalent states (2020) (13)
- An Arg/Ser substitution in the second epidermal growth factor-like module of factor IX introduces an O-linked carbohydrate and markedly impairs activation by factor XIa and factor VIIa/Tissue factor and catalytic efficiency of factor IXa. (1999) (12)
- Consequences of ligand bivalency in interactions involving particulate receptors: equilibrium and kinetic studies with Sephadex-concanavalin A, butylagarose-phosphorylase b, and Fc receptor-IgG dimer interactions as model systems. (1987) (12)
- Characterization of redox-active proteins on cell surface. (2002) (11)
- Evidence for multiple enzyme site involvement in the modulation of thrombin activity by products of prothrombin proteolysis. (1998) (10)
- Disulfide exchange in CD4 (2003) (9)
- Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells. (1995) (8)
- Thiol isomerase ERp57 targets and modulates the lectin pathway of complement activation (2019) (8)
- Blood vessels and nerves: together or not? (2002) (7)
- One-Way Allosteric Communication between the Two Disulfide Bonds in Tissue Factor (2017) (7)
- Sulfur Derivatives of the Natural Polyarsenical Arsenicin A: Biologically Active, Organometallic Arsenic–Sulfur Cages Related to the Minerals Realgar and Uzonite (2015) (7)
- Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function. (2010) (7)
- Molecular profiling of signalling proteins for effects induced by the anti-cancer compound GSAO with 400 antibodies (2006) (6)
- Structure/function analysis of a critical disulfide bond in the active site of l-xylulose reductase (2009) (6)
- 246 Heparin Promotes the Binding of Thrombin to Fibrin Polymer (2001) (6)
- Tissue factor activation involves disulfide switching (2005) (6)
- Tyrosine nitration moderates the peptidase activity of human methionyl aminopeptidase 2. (2013) (6)
- Evidence for the preferential interaction of micellar chlorpromazine with human serum albumin. (1984) (6)
- Effects of thermodynamic nonideality in kinetic studies: evidence of an expanded intermediate complex in the inactivation of thrombin by antithrombin III. (1991) (6)
- A perspective on the measurement of ADAMTS13 in thrombotic thrombocytopaenic purpura (2003) (6)
- Multiple Disulfide-Bonded States of Native Proteins: Estimate of Number Using Probabilities of Disulfide Bond Formation (2020) (5)
- Preparation of a Dithiol-Reactive Probe for PET Imaging of Cell Death. (2019) (5)
- First-in-man trial of 4-(N-(S-penicillaminylacetyl)amino) phenylarsonous acid (PENAO) as a continuous intravenous infusion (CIVI), in patients (pt) with advanced solid tumours. (2016) (5)
- Measurement of reduction of disulfide bonds in plasmin by phosphoglycerate kinase. (2002) (4)
- Structure-Function of Thrombospondins: Regulation of Fibrinolysis and Cell Adhesion (1993) (4)
- An alternate covalent form of platelet αIIbβ3 integrin that resides in focal adhesions and has altered function (2021) (4)
- Abstract 5287: Non-invasive imaging of tumor cell death using a Hsp90 ligand (2011) (4)
- Evaluation of a potential redox switch in blood coagulation tenase (2019) (3)
- DD-04PENAO: A POTENT MITOCHONDRIAL TARGETED INHIBITOR FOR GLIOBLASTOMA (2014) (3)
- Building an ER electron transport chain (2002) (3)
- tumour angiogenesis as a disulphide reductase (2000) (3)
- Identification of redox-active proteins on cell surface. (2002) (2)
- Influenza A virus hemagglutinin is produced in different disulfide-bonded states. (2021) (2)
- Molecular Switch between Tissue Factor-Mediated Signaling and Coagulation. (2005) (2)
- Visualization of Proteins and Cells Using Dithiol‐reactive Metal Complexes (2014) (2)
- Selective targeting of mitochondria for the treatment of cancer. (2005) (2)
- Classification of Protein Disulphide Bonds. (2019) (2)
- EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY (2013) (2)
- A first-in-human study of [68Ga]Ga-CDI: a positron emitting radiopharmaceutical for imaging tumour cell death (2022) (1)
- TMX1: a new vascular thiol isomerase. (2019) (1)
- Elimination of the antimicrobial action of the organoarsenical cancer therapeutic, 4‐(N‐(S‐glutathionylacetyl)amino) phenylarsonous acid, before finished product sterility testing (2013) (1)
- The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas (2020) (1)
- Selective inhibition of proliferating endothelial cells: A phase I study of the novel organoarsenical compound GSAO in patients with advanced solid tumors. (2010) (1)
- Allosteric Disulfide Bonds in Thrombosis and Thrombolysis. (2006) (1)
- Toxicokinetics of the tumour cell mitochondrial toxin, PENAO, in rodents (2021) (1)
- The tumour metabolism inhibitors GSAO and PENAO react with cysteines 57 and 257 of mitochondrial adenine nucleotide translocase (2012) (1)
- Optimization of theAntitumor Efficacy of a SyntheticMitochondrial Toxin by Increasing theResidence Time in the Cytosol (2009) (1)
- Protein function achieved through multiple covalent states (2019) (1)
- Preclinical assessment of [68Ga]Ga-Cell Death Indicator (CDI): a novel hsp90 ligand for positron emission tomography of cell death. (2021) (1)
- Mechanism of Selectivity of Arsenic Trioxide for Acute Promyelocytic Leukemia Cells from Screening a Genome Wide Set of Saccharomyces cerevisiae Deletion Strains. (2005) (1)
- Biodistribution and imaging of an hsp90 ligand labelled with 111In and 67Ga for imaging of cell death (2020) (1)
- Functional Disulphide Bonds (2019) (1)
- REACTIVE OXYGEN SPECIES AND p38 MAPK MEDIATE TNF-ALPHA CONVERTING ENZYME (TACE/ADAM17) ACTIVATION IN PRIMARY HUMAN MONOCYTES (2011) (1)
- Procoagulant Role Of Necrotic Platelets Demonstrated Using Novel Platelet Necrosis Marker (2013) (1)
- Abstract 1701: PENAO, a novel mitochondria-targeted agent, has shown potent antitumor effect on glioblastomain vitroandin vivo. (2013) (1)
- Novel and emerging therapies in cardiology and haematology. (2003) (1)
- Dynamic Disulfide Bond Topologies in von-Willebrand-Factor’s C4-Domain Undermine Platelet Binding (2022) (0)
- CCDC 1005782: Experimental Crystal Structure Determination (2015) (0)
- PDI Cleavage of Disulfide Bonds within the TP Receptor Inhibits Signaling through Gα 13 (2021) (0)
- Not one, but many forms of thrombosis proteins (2021) (0)
- Redox state of surface protein thiols in different lines of B16 melanoma (2006) (0)
- Mechano-Redox Control of Macrophage-1 Antigen De-Adhesion From ICAM-1 (Intercellular Adhesion Molecule 1) by Protein Disulfide Isomerase Promotes Directional Movement Under Flow. (2023) (0)
- Mechano-covalent protection of coagulation factor VIII by von Willebrand factor. (2022) (0)
- PRECLINICAL EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY (2010) (0)
- MHCCoreceptor for Binding to Class II Evidence for a Domain-Swapped CD4 Dimer (2013) (0)
- CHAPTER 2.3:Allosteric Disulfide Bonds (2018) (0)
- EXTH-20. TARGETING GLIOBLASTOMA METABOLISM THROUGH mTOR AND MITOCHONDRIAL INHIBITION (2016) (0)
- Zinc is a potent and specific inhibitor of IFN- l 3 signalling (2017) (0)
- Abstract 2824: PENAO: A small molecule tumor metabolism inhibitor (2011) (0)
- SLE and Antiphospholipid Syndrome [223–231] 223. Acid Disruption Biacore Analysis of Antibodies Against Rituximab in SLE Patients (2010) (0)
- A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours (2021) (0)
- de-encryption Critical importance of the cell system when studying tissue factor (2013) (0)
- Biochemical abnormalities in renal stone formers attending for lithotripsy (2007) (0)
- Endoplasmic reticulum protein 5 attenuates platelet endoplasmic reticulum stress and secretion in a mouse model. (2022) (0)
- Supplementary material from "Identification of allosteric disulfides from labile bonds in X-ray structures" (2018) (0)
- Tumor imaging using near-infrared labeled probes against proliferating endothelial cells (2001) (0)
- Blood Level of Phosphoglycerate Kinase Does not Correlate with Presence or Extent of Tumor (2004) (0)
- The cyclin-dependent kinase inhibitor, p21WAF1, is a resistance factor for histone deacetylase inhibitors, and induces angiogenesis via the thioredoxin pathway (2007) (0)
- EXTH-18. REPURPOSING IBUDILAST IN COMBINATION WITH TEMOZOLOMIDE FOR GLIOBLASTOMA (2016) (0)
- Sulfenylation links oxidative stress to protein disulfide isomerase oxidase activity and thrombus formation. (2023) (0)
- Control of blood clotting by an allosteric disulfide (2007) (0)
- Mechano-redox control of Mac-1 de-adhesion from ICAM-1 by protein disulfide isomerase promotes directional movement of neutrophils under flow (2022) (0)
- The major subpopulation of platelets involved in thrombus development form via regulated necrosis involving cyclophilin (2015) (0)
- Protein Disulphide Isomerase 6 (PDIA6) Attenuates Platelet Endoplasmic Reticulum Stress and Secretion in a Mouse Model (2021) (0)
- Anti-tumor effect and mechanisms of concurrent targeting EGFR and metabolism in sarcoma cell lines (2016) (0)
- PO-82 Endogenous production of nitric oxide controls the activation state of cell surface tissue factor (2007) (0)
- Receptor-mediated inhibitor-dependent catabolism of tissue type and urokinase plasminogen activator by hep G2 cells is distinct from other characterised receptor system (1994) (0)
- Allowance for ligand multivalency in binding studies (1987) (0)
- PhospholipidEnhance Prothrombin Binding to Lupus Antibody Bivalency Is Required to (2001) (0)
- Extracellular Protein Disulfide Isomerase Cleaves Allosteric Disulfides in Histidine-Rich Glycoprotein to Regulate Thrombus Formation (2020) (0)
- Dual-targeting of aberrant glucose metabolism in glioblastoma (2015) (0)
- Evidence for Control of von Willebrand Factor Multimer Size by Intramolecular Thiol-Disulfide Exchange. (2005) (0)
- Abstract 1131: Blocking ATP delivery to hexokinase II in glioblastoma is a promising therapeutic strategy (2012) (0)
- Preclinical development of a new leukaemia drug, PENAO (2007) (0)
- The von Willebrand factor A2 domain disulfide bond exists in oxidized and reduced states in the circulation and regulates function (2015) (0)
- Platelet Surface PDI Controls the Ligand-Binding Function of Glycoprotein Ibalpha and Platelet-Neutrophil Interactions Under Thromboinflammatory Conditions (2015) (0)
- Author response: Mechano-redox control of integrin de-adhesion (2018) (0)
- Molecular imaging of apoptosis in normal tissue utilizing a novel agent GSAO-Cy5.5 (2003) (0)
- Mechano-Redox Control of Mac-1 De-Adhesion by PDI Promotes Directional Movement Under Flow (2023) (0)
- Author response: Mechano-redox control of integrin de-adhesion (2018) (0)
- Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma (2022) (0)
- ATPS-09A MITOCHONDRIAL METABOLISM INHIBITOR RADIO-SENSITIZES GLIOBLASTOMA TUMOURS IN MICE. (2015) (0)
- Abstract 2604: PENAO: A novel tumor metabolism inhibitor for glioblastoma (2011) (0)
- Abstract 2868: Pancreatic tumor stromal cells express high levels of α-glutamyl transferase that may be employed to deliver a metabolism inhibitor to the tumor mass (2012) (0)
This paper list is powered by the following services:
Other Resources About Philip Hogg
What Schools Are Affiliated With Philip Hogg?
Philip Hogg is affiliated with the following schools:
